High-Dose Aspirin Consumption Contributes to Decreased Risk for Pancreatic Cancer in a Systematic Review and Meta-analysis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pancreas

• Publication date

  2014-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPA.0b013e3182a8d41fPMID 24263109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspirin and cancer risk: a quantitative review to 2011.

  2012cited by this paper
• Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case–Control Study

  2011cited by this paper
• Nutrients, Food Groups, Dietary Patterns, and Risk of Pancreatic Cancer in Postmenopausal Women

  2011cited by this paper
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011cited by this paper
• Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer

  2010cited by this paper
• COX-2 as a target for cancer chemotherapy

  2010cited by this paper
• Concurrent inhibition of NF‐κB, cyclooxygenase‐2, and epidermal growth factor receptor leads to greater anti‐tumor activity in pancreatic cancer

  2010cited by this paper
• Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

  2010cited by this paper
• Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Aspirin use and pancreatic cancer risk

  2010cited by this paper
• Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells.

  2009cited by this paper
• Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

  2009cited by this paper
• Publication bias in clinical trials due to statistical significance or direction of trial results.

  2009cited by this paper
• S40. Aspirin and cancer risk: a quantitative review

  2008cited by this paper
• Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.

  2008cited by this paper
• Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

  2007cited by this paper
• Random-effects model for meta-analysis of clinical trials: an update.

  2007cited by this paper
• Dietary Mutagen Exposure and Risk of Pancreatic Cancer

  2007cited by this paper
• Cyclooxygenases, prostanoids, and tumor progression

  2007cited by this paper
• Meta‐analysis: the use of non‐steroidal anti‐inflammatory drugs and pancreatic cancer risk for different exposure categories

  2007cited by this paper
• Aspirin and Nonsteroidal Anti-inflammatory Drug Use and Risk of Pancreatic Cancer: A Meta-analysis

  2006cited by this paper
• Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity.

  2006cited by this paper
• Generalized Least Squares for Trend Estimation of Summarized Dose–response Data

  2006cited by this paper
• Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin

  2005cited by this paper
• Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

  2005cited by this paper
• A prospective study of aspirin use and the risk of pancreatic cancer in women.

  2004cited by this paper
• Aspirin use and mortality from cancer in a prospective cohort study.

  2004cited by this paper
• Aspirin use and pancreatic cancer mortality in a large United States cohort.

  2004cited by this paper
• A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

  2004cited by this paper
• A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

  2003cited by this paper
• Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer.

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Regular use of aspirin and pancreatic cancer risk

  2002cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Advantages and disadvantages of the meta-analysis approach

  1996cited by this paper
• Methods for trend estimation from summarized dose-response data, with applications to meta-analysis.

  1992cited by this paper
• Cancer statistics

  1989cited by this paper
• Quantitative methods in the review of epidemiologic literature.

  1987cited by this paper

• Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions

  2024cites this paper
• Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers.

  2024cites this paper
• Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight

  2023cites this paper
• Synthesis, Characterization, and Investigation of Anti-Inflammatory and Cytotoxic Activities of Novel Thiourea Derivatives of Naproxen

  2023cites this paper
• Acetylsalicylic Acid–Primus Inter Pares in Pharmacology

  2022cites this paper
• NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase

  2022cites this paper
• Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals

  2022cites this paper
• Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity

  2021cites this paper
• Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer

  2021cites this paper
• OTT_A_281251 53..65

  2021cites this paper
• Aberrant Factors of Fibrinolysis and Coagulation in Pancreatic Cancer

  2021cites this paper
• Can aspirin use reduce the risk of pancreatic cancer: an updated systematic review and meta-analysis

  2020influential citation
• Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review

  2020influential citation
• Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.

  2020cites this paper
• Aspirin use and pancreatic cancer risk

  2019cites this paper
• Obesity, Type-2 Diabetes and Cancer: Mechanistic Insights.

  2019cites this paper
• Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.

  2018cites this paper
• Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study

  2018cites this paper
• Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma.

  2018cites this paper
• Pancreatic Cancer Epidemiology and Environmental Risk Factors

  2018cites this paper
• Melatonin May Increase Anticancer Potential of Pleiotropic Drugs

  2018cites this paper
• Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies

  2018cites this paper
• Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden

  2018cites this paper
• Inflammatory Potential of Diet And Pancreatic Cancer Risk: Interaction And Mediation Analysis In Two Prospective Cohorts

  2017cites this paper
• Targeting Inflammation to Improve Tumor Drug Delivery.

  2017cites this paper
• Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk

  2017cites this paper
• Inflammation-Related Pancreatic Carcinogenesis: Mechanisms and Clinical Potentials in Advances

  2017cites this paper
• Pancreatic cancer screening: Still a delusion?

  2017cites this paper
• The role of inflammatory modulators in chronic pancreatitis and the development of pancreatic cancer

  2017cites this paper
• Nitric Oxide Donors and Therapeutic Applications in Cancer

  2017cites this paper
• NO-H2S-Releasing Chimeras as a Multifaceted Approach to Cancer Therapy

  2017cites this paper
• Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice

  2016cites this paper
• The Significance of Ras Activity in Pancreatic Cancer Initiation

  2016cites this paper
• Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis

  2016cites this paper
• Pancreatic cancer biology and genetics from an evolutionary perspective

  2016cites this paper
• The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer

  2016cites this paper
• Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment.

  2016cites this paper
• Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials.

  2016cites this paper
• Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case–control study

  2016cites this paper
• Environmental risk factors for pancreatic cancer: an update

  2016cites this paper
• Fish, n-3 PUFA consumption, and pancreatic cancer risk in Japanese: a large, population-based, prospective cohort study.

  2015cites this paper
• Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies

  2015cites this paper
• Chronic Pancreatitis as an Inductor of Pancreatic Cancer — Correlations With Inflammatory Pathways

  2015cites this paper
• Pancreatic Inflammation and Carcinogenesis

  2015cites this paper
• Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies

  2015cites this paper
• NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties

  2015cites this paper
• Risk factors for pancreatic cancer: a summary review of meta-analytical studies.

  2015cites this paper
• Dissecting the Epidemiology of Pancreatic Adenocarcinoma

  2015cites this paper
• Epidemiology and etiology of pancreatic cancer

  2015cites this paper
• Pancreatic Cancer, Inflammation, and Microbiome

  2014cites this paper
• Is Chemoprevention of Pancreatic Cancer Possible by Aspirin Consumption

  2014cites this paper